Cleveland Diagnostics Launches Second Annual Prostate Cancer Awareness Campaign

Campaign Launch:
Cleveland Diagnostics is launching its second annual prostate cancer awareness campaign, "A PSA on PSA," starting September 1st.

Discussion Guide:
The campaign includes a downloadable discussion guide at PSAonPSA.com, which helps patients engage in more effective discussions with their healthcare providers about prostate cancer risk assessment.

Donations:
For each guide downloaded, Cleveland Diagnostics will contribute to ZERO Prostate Cancer, supporting research and resources in the battle against prostate cancer.

IsoPSA Test:
The IsoPSA test, developed by Cleveland Diagnostics, uses protein structure analysis to determine if elevated PSA levels are associated with cancer cells, aiming to reduce overdiagnosis and unnecessary invasive testing.

Early Detection:
The campaign emphasizes the importance of early detection, which significantly improves prostate cancer survival rates.

Partnership:
ZERO Prostate Cancer will match donations made during September to support the cause.